60° Pharmaceuticals
Manufacturing · District of Columbia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1025 Connecticut Ave NW Ste 1000, Washin...Phone Number
(202) 327-5422Website
www.60degreespharma.comRevenue
<$5 MillionStock Symbol
SXTPIndustry
About 60° Pharmaceuticals
60° Pharmaceuticals Org Chart
Is 60° Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on 60° Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when 60° Pharmaceuticals launches new products
Funding: Get notified immidiatlly once 60° Pharmaceuticals has new funding data
Check out if 60° Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if 60° Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at 60° Pharmaceuticals
60° Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if 60° Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to 60° Pharmaceuticals
Compare insights from companies similar to 60° Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
60° Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
60° Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about 60° Pharmaceuticals.
60° Pharmaceuticals financials insights
Gather financial insights about 60° Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$4M
60° Pharmaceuticals Tech Stack
A closer look at the technologies used by 60° Pharmaceuticals
Most Recent Scoops
60° Pharmaceuticals News & Media
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
60 Degrees Pharma enrolls first 2026 babesiosis trial patient ahead of schedule, supporting possible early interim analysis.60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results60 Degrees Pharmaceuticals Announces 2025 Annual Results
60 Degrees Pharma (Nasdaq: SXTP) FY25 revenue +65% to $1.0M; improved net loss; continued clinical, commercial, and partnership momentum.60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
All three patients in 60 Degrees Pharma’s expanded access study were cured of relapsing babesiosis after tafenoquine treatment, supporting guideline review
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 60° Pharmaceuticals
60 Degrees Pharmaceuticals focuses on addressing critical gaps in global health by developing pharmaceutical solutions for tropical diseases that disproportionately affect underserved populations. The company operates across the full spectrum of drug development, from initial discovery through clinical advancement to market distribution, enabling c... Read More